The Relationship between Epicardial Adipose Tissue Thickness and Serum Interleukin-17a Level in Patients with Isolated Metabolic Syndrome

dc.authorid0000-0003-1767-408X
dc.authorid0000-0002-8380-3065
dc.contributor.authorDemir, Esra
dc.contributor.authorHarmankaya, Nazmiye Ozlem
dc.contributor.authorUtku, Irem Kirac
dc.contributor.authorAciksari, Gonul
dc.contributor.authorUygun, Turgut
dc.contributor.authorOzkan, Hanise
dc.contributor.authorDemir, Bulent
dc.date.accessioned2025-05-10T19:36:50Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractIn this study, it was aimed to investigate the relationship between the epicardial adipose tissue thickness (EATT) and serum IL-17A level insulin resistance in metabolic syndrome patients. This study enrolled a total of 160 subjects, of whom 80 were consecutive patients who applied to our outpatient clinic and were diagnosed with metabolic syndrome, and the other 80 were consecutive patients who were part of the control group with similar age and demographics in whom the metabolic syndrome was excluded. The metabolic syndrome diagnosis was made according to International Diabetes Federation (IDF)-2005 criteria. EATT was measured with transthoracic echocardiography (TTE) in the subjects. IL-17A serum levels were determined using the ELISA method. Fasting blood glucose, HDL, triglyceride, and fasting insulin levels were significantly higher in the metabolic syndrome group compared to the control group. In addition, the metabolic syndrome group had significantly higher high-sensitivity C-reactive protein (hs-CRP) and Homeostatic Model Assessment Insulin Resistance (HOMA-IR) levels than the control group. Similarly, serum IL-17A levels were significantly elevated in the metabolic syndrome group compared to the control group statistically (p < 0.001). As well, EATT was higher in the metabolic syndrome than the control group. Conclusion: By virtue of their proinflammatory properties, EATT and IL-17 may play an important role in the pathogenesis of the metabolic syndrome.
dc.identifier.doi10.3390/biom9030097
dc.identifier.issn2218-273X
dc.identifier.issue3
dc.identifier.pmid30862094
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/biom9030097
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9304
dc.identifier.volume9
dc.identifier.wosWOS:000464411700004
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofBiomolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectmetabolic syndrome
dc.subjectadipose tissue
dc.subjectinterleukin 17A
dc.titleThe Relationship between Epicardial Adipose Tissue Thickness and Serum Interleukin-17a Level in Patients with Isolated Metabolic Syndrome
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9304.pdf
Boyut:
1013.29 KB
Biçim:
Adobe Portable Document Format